Gabra H, Watson J E, Taylor K J, Mackay J, Leonard R C, Steel C M, Porteous D J, Smyth J F
Imperial Cancer Research Fund, Western General Hospital, Edinburgh, United Kingdom.
Cancer Res. 1996 Mar 1;56(5):950-4.
Previous cytogenetic and loss of heterozygosity (LOH) data suggest that disruption of chromosome 11q23-qter occurs frequently in epithelial ovarian cancer and is associated with an adverse clinicopathological phenotype. Ten polymorphic microsatellite repeat loci were analyzed by PCR from the 11q22-q25 region between D11S35 and D11S968 in 40 ovarian tumors (including 31 epithelial ovarian cancers). Two distinct regions of loss were detected, suggesting possible sites for genes involved in epithelial ovarian neoplasia: a large centromeric region between D11S35 and D11S933 (11q22-q23.3) and a telomeric 8.5-Mb region lying between D11S934 and D11S1320 (11q23.3-24.3) not previously defined. LOH of the latter region but not the former one was significantly associated with poor survival, despite all tumors in this study having LOH somewhere on chromosome 11. This analysis provides a starting point for positional cloning.
先前的细胞遗传学和杂合性缺失(LOH)数据表明,11q23-qter染色体的破坏在上皮性卵巢癌中频繁发生,并且与不良的临床病理表型相关。通过PCR分析了40个卵巢肿瘤(包括31个上皮性卵巢癌)中位于D11S35和D11S968之间的11q22-q25区域的10个多态性微卫星重复位点。检测到两个不同的缺失区域,提示可能存在与上皮性卵巢肿瘤发生相关的基因位点:一个位于D11S35和D11S933之间的大的着丝粒区域(11q22-q23.3),以及一个位于D11S934和D11S1320之间的8.5Mb端粒区域(11q23.3-24.3),该区域此前未被定义。尽管本研究中的所有肿瘤在11号染色体的某个位置都存在LOH,但后一个区域而非前一个区域的LOH与较差的生存率显著相关。该分析为定位克隆提供了一个起点。